Activity in this selectiongoldman-sachs-3a257b4c
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $59.8M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionExcivaDevelops novel therapies for behavioral symptoms associated with Alzheimer's Disease
Role not disclosed